Ari M. Vanderwalde
ORCID: 0000-0002-6842-2563Also affiliated with Caris Life Sciences (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 11 papers. Top paper: “Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial”.
Shay Bellasea, Kari Kendra, Nikhil I. Khushalani, Katie M. Campbell, Philip O. Scumpia +28 more
Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Yasmine Baca, Joanne Xiu +14 more
Tolulope Adeyelu, Harris B. Krause, Andrew Elliott, Ranee Mehra, Heloisa P. Soares +8 more
Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more
Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more
John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more
Charles Coleman, Nishant Gandhi, Vrinda Jethalia, Deniz Demircioğlu, Andrew Elliott +9 more
Tolulope Adeyelu, Wei‐Zen Wei, Andrew Elliott, Gerold Bepler, Ari M. Vanderwalde +5 more
Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more
Jennifer R. Ribeiro, Jun Yin, Joanne Xiu, Matías A. Bustos, Fumito Ito +17 more
Nishant Gandhi, Chul Kim, Hirva Mamdani, Balázs Halmos, Ari M. Vanderwalde +5 more